1. Home
  2. TRTX vs YDES Comparison

TRTX vs YDES Comparison

Compare TRTX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$6.24

Market Cap

471.4M

Sector

Real Estate

ML Signal

HOLD

Logo YD Bio Limited Ordinary Shares

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$4.25

Market Cap

476.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRTX
YDES
Founded
2014
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
471.4M
476.8M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
TRTX
YDES
Price
$6.24
$4.25
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $9.54
N/A
AVG Volume (30 Days)
★ 1.4M
369.9K
Earning Date
10-26-2026
08-31-2026
Dividend Yield
★ 16.41%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.31
N/A
P/E Ratio
$30.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.57
$1.70
52 Week High
$9.37
$18.57

Technical Indicators

Market Signals
Indicator
TRTX
YDES
Relative Strength Index (RSI) 46.61 39.75
Support Level $5.57 $2.33
Resistance Level $8.74 $5.15
Average True Range (ATR) 0.21 1.00
MACD 0.07 -0.29
Stochastic Oscillator 87.59 0.59

Price Performance

Historical Comparison
TRTX
YDES

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Share on Social Networks: